The global Anxiety Disorder and Depression Treatment Market was valued at USD 18.35 billion in 2022, with an expected revenue CAGR of 2.5% over the forecast period to reach USD 22.92 billion by 2032. The market growth is driven by various factors such as the increasing prevalence of anxiety and depressive disorders globally, rising public awareness of the importance of mental health, and...